Sanofi’s Tzield (teplizumab) has received expanded approved from the US FDA, allowing it to be used for children aged one ...

Helus Pharma, a clinical stage pharmaceutical company committed to helping minds heal by developing novel serotonergic ...

AI is fundamentally changing the way marketing operates omnichannel journeys, enabling true next-best communication ...

Merck’s Enflonsia (clesrovimab) has been approved by the European Commission for the prevention of respiratory syncytial ...

AstraZeneca has reported positive high-level results from the phase 3 MIRANDA trial of tozorakimab, showing a statistically ...

Rebuilding them as AI-first workflows gives emerging biopharma big-agency capability on a start-up budget. Rather than ...

Explore real patient conversations about weight loss drugs, uncovering challenges, support strategies, and the critical need ...

Behaviour change is not primarily a matter of information or intention, but of habit, environment, identity and reward ...

Eli Lilly has agreed to acquire Kelonia Therapeutics in a deal valued at up to $7bn, as the company looks to expand its ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation to Biogen for a ...

In our cover story this month, Danny Buckland looks at weight loss medication and how GLP-1s have been shown to provide game-changing opportunities for patients who are overweight or obese to improve ...

Icotyde (icotrokinra) has been approved by the US FDA to treat moderate-to-severe plaque psoriasis (PsO) in both adults and ...